🚀 Pharmidex In Silico Drug Discovery – Step 4: Molecular Docking! 🔬💻
February 26, 2025

Pharmidex continues advancing computational drug discovery! After identifying active/binding sites, our Molecular Docking step ensures precise interaction analysis between potential drug candidates and target proteins, streamlining lead optimization.


✨ Why is this step key?

✅ Predicts binding affinity and stability of drug candidates

✅ AI-enhanced docking for high-precision molecular interactions

✅ Accelerates hit-to-lead identification with accurate simulations

✅ Seamlessly integrates with the next in silico pipeline steps


By combining cutting-edge modeling and expert-driven analysis, we de-risk drug development and fast-track novel therapeutic discoveries.


📽️ Watch our latest video (3/5) showcasing how we refine drug-target interactions through Molecular Docking!


📩 Let’s collaborate to transform drug discovery!


#DrugDiscovery #Pharmidex #AIinBiotech #MolecularDocking #PharmaceuticalInnovation

April 30, 2025
We’re excited to share that Ash Alavijeh , our Head of Operations, will attend the Swiss Biotech Day 2025 on May 5–6 at the Congress Center Basel, Switzerland! 🔗 https://swissbiotechday.ch Ash looks forward to connecting with attendees to explore new collaborations and drive drug discovery and development forward. If you're in Basel, let's meet and discuss how we can advance the next wave of innovative therapies together.
April 28, 2025
We are pleased to announce that Martin Barrett , our Head of Business Development, will be attending the Making & Distributing Pharmaceuticals UK event on 29–30 April 2025 at the Coventry Building Society Arena! 🔗 ( https://lnkd.in/gd73pvE ) Martin would be delighted to meet with fellow attendees to discuss new collaboration opportunities and how we can work together to advance the development of innovative drug candidates. If you are attending, don’t miss the chance to connect with us and explore how we can drive pharmaceutical progress forward together!
April 28, 2025
We’re excited that Ash Alavijeh , our Head of Operations, will attend the Biotech Matchmaking Event on 29 April 2025 at the Old Divinity School, St John’s College, Cambridge. 🔗 (Biotech Matchmaking Event - The Milner Therapeutics Institute) Ash looks forward to meeting attendees, discussing new collaborations, and driving forward the development of innovative drug candidates.  If you're attending, let’s connect and explore new opportunities together!
More Posts